SF3B1 and intrahepatic cholangiocarcinoma: Concordant with the IWG-PM, ICC also excludes RUNX1 mutations from the SF3B1 entity supported by our data showing RUNX1 mutations as independent negative prognostic factors for OS and AML transformation.